Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000022

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 17, 2018
Accepted (ET)
Apr 25, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 17, 2018P1,000$0.034A24,955,789D
Common StockApr 17, 2018P1,000$0.0344A24,956,789D
Common StockApr 17, 2018P1,000$0.0388A24,957,789D
Common StockApr 17, 2018P1,000$0.0379A24,958,789D
Common StockApr 18, 2018P1,000$0.0389A24,959,789D
Common StockApr 18, 2018P1,000$0.039A24,960,789D
Common StockApr 18, 2018P1,000$0.0394A24,961,789D
Common StockApr 18, 2018P1,000$0.0389A24,962,789D
Common StockApr 19, 2018P1,000$0.0383A24,963,789D
Common StockApr 19, 2018P1,000$0.0383A24,964,789D
Common StockApr 19, 2018P1,000$0.0379A24,965,789D
Common StockApr 19, 2018P1,000$0.0385A24,966,789D
Common StockApr 19, 2018P1,000$0.0384A24,967,789D
Common StockApr 20, 2018P1,000$0.036A24,968,789D
Common StockApr 20, 2018P1,000$0.0361A24,969,789D
Common StockApr 20, 2018P1,000$0.0375A24,970,789D
Common StockApr 23, 2018P1,000$0.0364A24,971,789D
Common StockApr 24, 2018P1,000$0.036A24,972,789D
Common StockApr 24, 2018P1,000$0.036A24,973,789D
Common StockApr 24, 2018P1,000$0.036A24,974,789D

Table II — derivative securities

No Table II lines on this filing.